{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:05:43Z","timestamp":1789455943679,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00234-026-04086-6","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:42:04Z","timestamp":1782722524000},"page":"2175-2187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study of radiomics features between ASL and DSC perfusion-weighted imaging in distinguishing radiation-induced brain injury from glioma recurrence"],"prefix":"10.1007","volume":"68","author":[{"given":"Yanhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"4086_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","DOI":"10.1093\/neuonc\/noac202"},{"key":"4086_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","volume":"499","author":"T Jiang","year":"2021","unstructured":"Jiang T, Nam D-H, Ram Z et al (2021) Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett 499:60\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.050","journal-title":"Cancer Lett"},{"key":"4086_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00062-017-0584-x","volume":"28","author":"AW Abbasi","year":"2018","unstructured":"Abbasi AW, Westerlaan HE, Holtman GA, Aden KM, van Laar PJ, van der Hoorn A (2018) Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis. Clin Neuroradiol 28:401\u2013411. https:\/\/doi.org\/10.1007\/s00062-017-0584-x","journal-title":"Clin Neuroradiol"},{"key":"4086_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/neuonc\/now194","volume":"19","author":"SE van West","year":"2017","unstructured":"van West SE, de Bruin HG, van de Langerijt B, Swaak-Kragten AT, van den Bent MJ, Taal W (2017) Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy. Neuro Oncol 19:719\u2013725. https:\/\/doi.org\/10.1093\/neuonc\/now194","journal-title":"Neurooncology"},{"issue":"1","key":"4086_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2176\/nmc.ra.2014-0188","volume":"55","author":"S-I Miyatake","year":"2015","unstructured":"Miyatake S-I, Nonoguchi N, Furuse M et al (2015) Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain. Neurol Med Chir (Tokyo) 55(1):50\u201359. https:\/\/doi.org\/10.2176\/nmc.ra.2014-0188","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4086_CR6","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.3390\/ijms150711832","volume":"15","author":"K Parvez","year":"2014","unstructured":"Parvez K, Parvez A, Zadeh G (2014) The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci 15:11832\u201311846. https:\/\/doi.org\/10.3390\/ijms150711832","journal-title":"Int J Mol Sci"},{"issue":"33","key":"4086_CR7","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY, Bent Mvd, Youssef G et al (2023) RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol 41(33):5187\u20135199. https:\/\/doi.org\/10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"issue":"13","key":"4086_CR8","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.3390\/cancers14133128","volume":"14","author":"E Testa","year":"2022","unstructured":"Testa E, Palazzo C, Mastrantonio R, Viscomi MT (2022) Dynamic Interactions between Tumor Cells and Brain Microvascular Endothelial Cells in Glioblastoma. Cancers 14(13):3128. https:\/\/doi.org\/10.3390\/cancers14133128","journal-title":"Cancers"},{"key":"4086_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1148\/radiol.2021210044","volume":"300","author":"M Alabousi","year":"2021","unstructured":"Alabousi M, Davenport MS (2021) Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training. Radiology 300:279\u2013284. https:\/\/doi.org\/10.1148\/radiol.2021210044","journal-title":"Radiology"},{"key":"4086_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/neuonc\/noaa141","volume":"22","author":"JL Boxerman","year":"2020","unstructured":"Boxerman JL, Quarles CC, Hu LS et al (2020) Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol 22:1262\u20131275. https:\/\/doi.org\/10.1093\/neuonc\/noaa141","journal-title":"Neurooncology"},{"key":"4086_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.mric.2012.07.007","volume":"20","author":"J-C Ferr\u00e9","year":"2012","unstructured":"Ferr\u00e9 J-C, Shiroishi MS, Law M (2012) Advanced techniques using contrast media in neuroimaging. Magn Reson Imaging Clin N Am 20:699\u2013713. https:\/\/doi.org\/10.1016\/j.mric.2012.07.007","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"4086_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00234-015-1571-z","volume":"57","author":"M Grade","year":"2015","unstructured":"Grade M, Hernandez Tamames JA, Pizzini FB, Achten E, Golay X, Smits M (2015) A neuroradiologist\u2019s guide to arterial spin labeling MRI in clinical practice. Neuroradiology 57:1181\u20131202. https:\/\/doi.org\/10.1007\/s00234-015-1571-z","journal-title":"Neuroradiology"},{"key":"4086_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/jmri.27823","volume":"55","author":"S Amemiya","year":"2022","unstructured":"Amemiya S, Watanabe Y, Takei N et al (2022) Arterial Transit Time-Based Multidelay Combination Strategy Improves Arterial Spin Labeling Cerebral Blood Flow Measurement Accuracy in Severe Steno-Occlusive Diseases. J Magn Reson Imaging 55:178\u2013187. https:\/\/doi.org\/10.1002\/jmri.27823","journal-title":"J Magn Reson Imaging: JMRI"},{"key":"4086_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11060-020-03475-y","volume":"147","author":"P Manning","year":"2020","unstructured":"Manning P, Daghighi S, Rajaratnam MK et al (2020) Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol 147:681\u2013690. https:\/\/doi.org\/10.1007\/s11060-020-03475-y","journal-title":"J Neurooncol"},{"key":"4086_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.radonc.2018.01.009","volume":"129","author":"Y-L Wang","year":"2018","unstructured":"Wang Y-L, Chen S, Xiao H-F et al (2018) Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging. Radiother Oncol 129:68\u201374. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.009","journal-title":"Radiother Oncol"},{"key":"4086_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3174\/ajnr.A7771","volume":"44","author":"TB Nguyen","year":"2023","unstructured":"Nguyen TB, Zakhari N, Velasco Sandoval S et al (2023) Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study. Am J Neuroradiol 44:134\u2013142. https:\/\/doi.org\/10.3174\/ajnr.A7771","journal-title":"AJNR Am J Neuroradiol"},{"key":"4086_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jmri.25023","volume":"43","author":"T Wang","year":"2016","unstructured":"Wang T, Li Y, Guo X et al (2016) Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling. J Magn Reson imaging 43:635\u2013643. https:\/\/doi.org\/10.1002\/jmri.25023","journal-title":"J Magn Reson imaging: JMRI"},{"key":"4086_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3174\/ajnr.A4759","volume":"37","author":"K Leu","year":"2016","unstructured":"Leu K, Boxerman JL, Cloughesy TF et al (2016) Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange. Am J Neuroradiol 37:1440\u20131446. https:\/\/doi.org\/10.3174\/ajnr.A4759","journal-title":"AJNR Am J Neuroradiol"},{"key":"4086_CR19","doi-asserted-by":"publisher","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","volume":"8","author":"UN Chukwueke","year":"2019","unstructured":"Chukwueke UN, Wen PY (2019) Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol 8:CNS28. https:\/\/doi.org\/10.2217\/cns-2018-0007","journal-title":"CNS Oncol"},{"key":"4086_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T (2005) Regularization and Variable Selection Via the Elastic Net. J Royal Stat Soc Ser B: Stat Methodol 67:301\u2013320.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"key":"4086_CR21","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1007\/s10489-021-02298-2","volume":"51","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zheng X, Pang Q, Zhou W (2021) Fast Gaussian kernel support vector machine recursive feature elimination algorithm. Appl Intell 51:9001\u20139014. https:\/\/doi.org\/10.1007\/s10489-021-02298-2","journal-title":"Appl Intell"},{"key":"4086_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology 295:328\u2013338. https:\/\/doi.org\/10.1148\/radiol.2020191145","journal-title":"Radiology"},{"key":"4086_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cancers13040647","volume":"13","author":"R Gutsche","year":"2021","unstructured":"Gutsche R, Scheins J, Kocher M et al (2021) Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients. Cancers 13:647. https:\/\/doi.org\/10.3390\/cancers13040647","journal-title":"Cancers"},{"key":"4086_CR24","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1038\/s41598-020-62658-9","volume":"10","author":"T Hashido","year":"2020","unstructured":"Hashido T, Saito S, Ishida T (2020) A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas. Sci Rep 10:6121. https:\/\/doi.org\/10.1038\/s41598-020-62658-9","journal-title":"Sci Rep"},{"key":"4086_CR25","doi-asserted-by":"publisher","first-page":"101864","DOI":"10.1016\/j.nicl.2019.101864","volume":"23","author":"B Ji","year":"2019","unstructured":"Ji B, Wang S, Liu Z et al (2019) Revealing hemodynamic heterogeneity of gliomas based on signal profile features of dynamic susceptibility contrast-enhanced MRI. NeuroImage Clin 23:101864. https:\/\/doi.org\/10.1016\/j.nicl.2019.101864","journal-title":"NeuroImage Clin"},{"key":"4086_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11307-018-1289-5","volume":"21","author":"A Stadlbauer","year":"2019","unstructured":"Stadlbauer A, Roessler K, Zimmermann M et al (2019) Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment. Mol Imaging Biology 21:747\u2013757. https:\/\/doi.org\/10.1007\/s11307-018-1289-5","journal-title":"Mol Imaging Biology"},{"key":"4086_CR27","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/neuonc\/noy066","volume":"20","author":"A Stadlbauer","year":"2018","unstructured":"Stadlbauer A, Zimmermann M, Doerfler A et al (2018) Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma. Neuro Oncol 20:1536\u20131546. https:\/\/doi.org\/10.1093\/neuonc\/noy066","journal-title":"Neurooncology"},{"key":"4086_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/mrm.20029","volume":"51","author":"Y Sun","year":"2004","unstructured":"Sun Y, Schmidt NO, Schmidt K et al (2004) Perfusion MRI of U87 brain tumors in a mouse model. Magn Reson Med 51:893\u2013899. https:\/\/doi.org\/10.1002\/mrm.20029","journal-title":"Magn Reson Med"},{"key":"4086_CR29","doi-asserted-by":"publisher","first-page":"e190168","DOI":"10.1148\/ryai.2020190168","volume":"2","author":"R Verma","year":"2020","unstructured":"Verma R, Correa R, Hill VB et al (2020) Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study. Radiol Artif Intell 2:e190168. https:\/\/doi.org\/10.1148\/ryai.2020190168","journal-title":"Radiol Artif Intell"},{"key":"4086_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/jmri.1073","volume":"13","author":"EL Barbier","year":"2001","unstructured":"Barbier EL, Lamalle L, D\u00e9corps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13:496\u2013520. https:\/\/doi.org\/10.1002\/jmri.1073","journal-title":"J Magn Reson Imaging: JMRI"},{"key":"4086_CR31","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1007\/s00330-022-09365-3","volume":"33","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wu Y, Wang Y et al (2023) Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Eur Radiol 33:3332\u20133342. https:\/\/doi.org\/10.1007\/s00330-022-09365-3","journal-title":"Eur Radiol"},{"key":"4086_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1148\/radiol.10091461","volume":"256","author":"HS Kim","year":"2010","unstructured":"Kim HS, Kim J-H, Kim S-H, Cho K-G, Kim SY (2010) Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence. Radiology 256:906\u2013915. https:\/\/doi.org\/10.1148\/radiol.10091461","journal-title":"Radiology"},{"key":"4086_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jmri.22801","volume":"35","author":"JR Fink","year":"2012","unstructured":"Fink JR, Carr RB, Matsusue E et al (2012) Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. J Magn Reson Imaging 35:56\u201363. https:\/\/doi.org\/10.1002\/jmri.22801","journal-title":"J Magn Reson Imaging: JMRI"},{"key":"4086_CR34","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.21037\/qims-22-32","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang Y, Wang Y et al (2022) Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression. Quant Imaging Med Surg 12:4805\u20134822. https:\/\/doi.org\/10.21037\/qims-22-32","journal-title":"Quant Imaging Med Surg"},{"key":"4086_CR35","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.3390\/cancers15184429","volume":"15","author":"M Alizadeh","year":"2023","unstructured":"Alizadeh M, Broomand Lomer N, Azami M et al (2023) Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme. Cancers 15:4429. https:\/\/doi.org\/10.3390\/cancers15184429","journal-title":"Cancers"},{"key":"4086_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/neuonc\/noy133","volume":"21","author":"JY Kim","year":"2019","unstructured":"Kim JY, Park JE, Jo Y et al (2019) Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro Oncol 21:404\u2013414. https:\/\/doi.org\/10.1093\/neuonc\/noy133","journal-title":"Neurooncology"},{"key":"4086_CR37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/RCT.0000000000001180","volume":"45","author":"T Hashido","year":"2021","unstructured":"Hashido T, Saito S, Ishida T (2021) Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging. J Comput Assist Tomogr 45:606\u2013613. https:\/\/doi.org\/10.1097\/RCT.0000000000001180","journal-title":"J Comput Assist Tomogr"},{"key":"4086_CR38","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1007\/s00330-023-09459-6","volume":"33","author":"D Pei","year":"2023","unstructured":"Pei D, Guan F, Hong X et al (2023) Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas. Eur Radiol 33:3455\u20133466. https:\/\/doi.org\/10.1007\/s00330-023-09459-6","journal-title":"Eur Radiol"},{"key":"4086_CR39","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1007\/s00330-019-06548-3","volume":"30","author":"M Kim","year":"2020","unstructured":"Kim M, Jung SY, Park JE et al (2020) Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol 30:2142\u20132151. https:\/\/doi.org\/10.1007\/s00330-019-06548-3","journal-title":"Eur Radiol"},{"key":"4086_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3389\/fnins.2016.00615","volume":"10","author":"A Ion-M\u0103rgineanu","year":"2016","unstructured":"Ion-M\u0103rgineanu A, Van Cauter S, Sima DM et al (2016) Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features. Front NeuroSci 10:615. https:\/\/doi.org\/10.3389\/fnins.2016.00615","journal-title":"Front NeuroSci"},{"key":"4086_CR41","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s00330-018-5704-8","volume":"29","author":"C Su","year":"2019","unstructured":"Su C, Jiang J, Zhang S et al (2019) Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour. Eur Radiol 29:1986\u20131996. https:\/\/doi.org\/10.1007\/s00330-018-5704-8","journal-title":"Eur Radiol"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-026-04086-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:11:39Z","timestamp":1789452699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-026-04086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4086"],"URL":"https:\/\/doi.org\/10.1007\/s00234-026-04086-6","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Ethics Committee of Chinese PLA General Hospital (Approval No. S2023_581_01). Due to the retrospective nature of the study and the use of anonymized data, the requirement for written informed consent was waived by the aforementioned Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}